27 October 2022 - The Department of Health & Aged Care has produced a two page summary on the upcoming health technology assessment review.

The review is to consider a number of important areas including:

• The selection of comparator(s)
• Methods for evaluating rare diseases for reimbursement and alternative funding pathways if required
• Methods for evaluating new and emerging technologies (including cell and gene therapies, and other precision-based medicines) and the suitability of existing funding pathways as required
• Methods for evaluating all new medicines and vaccines
• Use of real-world evidence including from sources other than randomised controlled trials
• Managing clinical, economic, financial and other uncertainty
• The feasibility of international work-sharing for reimbursement submissions

Read Department of Health & Aged Care document